Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study

Background IgG4 is associated with two emerging groups of rare diseases: 1) IgG4 autoimmune diseases (IgG4-AID) and 2) IgG4-related diseases (IgG4-RLD). Anti-neuronal IgG4-AID include MuSK myasthenia gravis, LGI1- and Caspr2-encephalitis and autoimmune nodo-/paranodopathies (CNTN1/Caspr1 or NF155 antibodies). IgG4-RLD is a multiorgan disease hallmarked by tissue-destructive fibrotic lesions with lymphocyte and IgG4 plasma cell infiltrates and increased serum IgG4 concentrations. It is unclear whether IgG4-AID and IgG4-RLD share relevant clinical and immunopathological features. Methods We collected and analyzed clinical, serological, and histopathological data in 50 patients with anti-neuronal IgG4-AID and 19 patients with IgG4-RLD. Results A significantly higher proportion of IgG4-RLD patients had serum IgG4 elevation when compared to IgG4-AID patients (52.63% vs. 16%, p = .004). Moreover, those IgG4-AID patients with elevated IgG4 did not meet the diagnostic criteria of IgG4-RLD, and their autoantibody titers did not correlate with their serum IgG4 concentrations. In addition, patients with IgG4-RLD were negative for anti-neuronal/neuromuscular autoantibodies and among these patients, men showed a significantly higher propensity for IgG4 elevation, when compared to women (p = .005). Last, a kidney biopsy from a patient with autoimmune paranodopathy due to CNTN1/Caspr1-complex IgG4 autoantibodies and concomitant nephrotic syndrome did not show fibrosis or IgG4+ plasma cells, which are diagnostic hallmarks of IgG4-RLD. Conclusion Our observations suggest that anti-neuronal IgG4-AID and IgG4-RLD are most likely distinct disease entities.

[1]  D. Tang,et al.  Mechanisms of Primary Membranous Nephropathy , 2021, Biomolecules.

[2]  A. Fernández-Codina,et al.  Emerging therapy options for IgG4-related disease , 2021, Expert review of clinical immunology.

[3]  F. Leypoldt,et al.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common? , 2021, Frontiers in Immunology.

[4]  H. Cathro,et al.  Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy , 2020, Kidney medicine.

[5]  J. Stone,et al.  IgG4-related disease: an update on pathophysiology and implications for clinical care , 2020, Nature Reviews Rheumatology.

[6]  A. Vincent,et al.  Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment , 2020, Frontiers in Molecular Neuroscience.

[7]  I. Koneczny.  Update on IgG4-mediated autoimmune diseases: New insights and new family members. , 2020, Autoimmunity reviews.

[8]  B. Qaqish,et al.  A Lutzomyia longipalpis salivary protein induces cross-reactive antibodies to pemphigus autoantigen desmoglein-1. , 2020, The Journal of investigative dermatology.

[9]  J. Stone,et al.  Immunoglobulin G (IgG) and IgG Subclass Concentrations Differ According to Sex and Race. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  C. Terao,et al.  Genetic analysis of IgG4-related disease , 2020, Modern rheumatology.

[11]  Amita Sharma,et al.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease , 2019, Annals of the rheumatic diseases.

[12]  Y. Parman,et al.  Relation of HLA‐DRB1 to IgG4 autoantibody and cytokine production in muscle‐specific tyrosine kinase myasthenia gravis (MuSK‐MG) , 2019, Clinical and experimental immunology.

[13]  N. Gilhus,et al.  Myasthenia gravis , 2019, Nature Reviews Disease Primers.

[14]  G. Kasprian,et al.  Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab , 2019, Neuropediatrics.

[15]  M. Kawakami,et al.  Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature , 2019, Immunologic Research.

[16]  M. Kawano,et al.  The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease? , 2019, Modern rheumatology.

[17]  D. Salant.  Unmet challenges in membranous nephropathy , 2019, Current opinion in nephrology and hypertension.

[18]  Yong-Beom Park,et al.  No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study , 2018, Clinical Rheumatology.

[19]  J. Hainfellner,et al.  Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank , 2018, Biopreservation and biobanking.

[20]  J. Kira,et al.  Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey , 2018, Front. Neurol..

[21]  U. Rescher,et al.  Annexins in Translational Research: Hidden Treasures to Be Found , 2018, International journal of molecular sciences.

[22]  K. Nakanishi,et al.  Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis , 2018, BMC Nephrology.

[23]  A. Erickson,et al.  IgG-4 Related Disease: An Introduction. , 2018, Missouri medicine.

[24]  I. Koneczny.  A New Classification System for IgG4 Autoantibodies , 2018, Front. Immunol..

[25]  P. Guilpain,et al.  Comment on the article entitled "Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome" (Autoimmunity Reviews 16 (2017) 1036-1043). , 2018, Autoimmunity reviews.

[26]  H. Vos,et al.  Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease , 2017, Gut.

[27]  J. Stone,et al.  Medical mirroring: granulomatosis with polyangiitis (formerly Wegener's) mimicking immunoglobulin‐G4 related disease , 2015, International journal of rheumatic diseases.

[28]  A. Vaglio,et al.  Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome. , 2017, Autoimmunity reviews.

[29]  M. Titulaer,et al.  Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies) , 2017, Current opinion in neurology.

[30]  Andreas Handel,et al.  Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells , 2017, Nature.

[31]  J. Stone,et al.  Is MuSK myasthenia gravis linked to IgG4-related disease? , 2017, Journal of Neuroimmunology.

[32]  Y. Shoenfeld,et al.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity , 2017, Immunologic research.

[33]  L. Marshall,et al.  Pemphigus , 2017, Nature Reviews Disease Primers.

[34]  E. Sánchez,et al.  Anti-LGI1 encephalitis , 2016, Neurology.

[35]  J. Stone,et al.  Antineutrophil cytoplasmic antibody positivity in IgG4-related disease , 2016, Medicine.

[36]  Tomohiro Watanabe,et al.  Pathogenicity of IgG in patients with IgG4-related disease , 2016, Gut.

[37]  J. Verschuuren,et al.  The expanding field of IgG4‐mediated neurological autoimmune disorders , 2015, European journal of neurology.

[38]  A. Payne,et al.  The dual nature of interleukin-10 in pemphigus vulgaris. , 2015, Cytokine.

[39]  E. Rosser,et al.  Regulatory B cells: origin, phenotype, and function. , 2015, Immunity.

[40]  Kenichi Yoshida,et al.  A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis , 2015, Pituitary.

[41]  E. Lerma,et al.  Thrombotic thrombocytopenic purpura. , 2014, Disease-a-month : DM.

[42]  P. Christadoss,et al.  Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice. , 2014, Clinical immunology.

[43]  R. Blesa,et al.  Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg , 2014, Neurology.

[44]  P. Young.  [Granulomatosis with polyangiitis]. , 2014, Medicina.

[45]  C. Palazzo,et al.  IgG4-related disease. , 2014, Joint, bone, spine : revue du rhumatisme.

[46]  A. Vincent,et al.  MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters , 2013, PloS one.

[47]  C. Akdis,et al.  IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. , 2013, The Journal of allergy and clinical immunology.

[48]  R. Takayanagi,et al.  Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. , 2013, World journal of gastroenterology.

[49]  M. Uhlén,et al.  Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation. , 2013, Kidney international.

[50]  T. Funakoshi,et al.  Enrichment of total serum IgG4 in patients with pemphigus , 2012, The British journal of dermatology.

[51]  D. Sahani,et al.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. , 2012, Arthritis and rheumatism.

[52]  A. Masamune,et al.  Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009 , 2012, International journal of rheumatology.

[53]  J. Ryu,et al.  Increased IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis: A Diagnostic Pitfall of IgG4-Related Disease , 2012, International journal of rheumatology.

[54]  Hisanori UmeharaKazuichi.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2012 .

[55]  I. Narita,et al.  Thrombotic thrombocytopenic purpura in IgG4‐related disease with severe deficiency of ADAMTS‐13 activity and IgG4 autoantibody against ADAMTS‐13 , 2011, Arthritis care & research.

[56]  K. Strauss,et al.  Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia , 2011, Annals of neurology.

[57]  C. Akdis,et al.  In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure , 2008, The Journal of experimental medicine.

[58]  C. Akdis,et al.  Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll‐like receptors , 2008, Allergy.

[59]  T. Nishikawa,et al.  Novel System Evaluating In Vivo Pathogenicity of Desmoglein 3-Reactive T Cell Clones Using Murine Pemphigus Vulgaris1 , 2008, The Journal of Immunology.

[60]  P. Parren,et al.  Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange , 2007, Science.

[61]  C. Hung,et al.  Glomerulonephritis Associated with Chronic Inflammatory Demyelinating Polyneuropathy , 2006, Renal failure.

[62]  A. Hoerauf,et al.  T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-101 , 2005, The Journal of Immunology.

[63]  H. Emsley,et al.  Inflammatory demyelinating polyradiculoneuropathy associated with membranous glomerulonephritis and thrombocytopaenia , 2002, Clinical Neurology and Neurosurgery.

[64]  David Gray,et al.  B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.

[65]  R. Blumberg,et al.  Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. , 2002, Immunity.

[66]  T. Nishikawa,et al.  Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. , 2002, The Journal of investigative dermatology.

[67]  J. Russell,et al.  Chronic inflammatory demyelinating polyneuropathy and membranous glomerulonephropathy: report of two cases. , 2001, Journal of clinical neuromuscular disease.

[68]  R. Mobbs,et al.  Chronic inflammatory demyelinating polyneuropathy associated with membranous glomerulonephritis: case report , 2000, Journal of Clinical Neuroscience.

[69]  M. Nagata,et al.  [Renal glucosuria and membranous glomerulonephritis in chronic inflammatory demyelinating polyradiculoneuropathy: CIDP]. , 1999, Nihon Jinzo Gakkai shi.

[70]  J. Bonnefoy,et al.  IgE versus IgG4 production can be differentially regulated by IL-10. , 1998, Journal of immunology.

[71]  G. Eknoyan,et al.  Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[72]  P. Vialtel,et al.  Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. , 1995, Transplantation.

[73]  D. Bronson,et al.  Identification and characterization of the human cell adhesion molecule contactin. , 1994, Brain research. Molecular brain research.

[74]  R. de Waal Malefyt,et al.  Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[75]  V. Kher,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy with membranous glomerulonephritis: report of one case , 1992, Clinical Neurology and Neurosurgery.

[76]  F. Boctor,et al.  IgG subclasses in human chronic schistosomiasis: over‐production of schistosome‐specific and non‐specific IgG4 , 1990, Clinical and experimental immunology.

[77]  J. Burke,et al.  Membranous glomerulonephritis associated with chronic progressive demyelinating neuropathy , 1987, Neurology.

[78]  M. Daveau,et al.  Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies. , 1984, Journal of immunological methods.

[79]  D. Kemeny,et al.  Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens. , 1983, The Journal of allergy and clinical immunology.

[80]  D. Kemeny,et al.  Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy. , 1983, Monographs in allergy.